BioDirection's Series C Round

BioDirection raised a round of funding on April 10, 2017.

BioDirection is a medical device company developing novel and rapid point-of care products for the objective management of concussion and other traumatic brain injuries (TBI). The company's first prod…

Articles about BioDirection's Series C Round: